Company page

Cybin, Inc.

Cybin, Inc. is a public company traded under the ticker HELP on the Canadian market. With a market capitalization of approximately $1.37 million, Cybin focuses on developing innovative therapies in the field of mental health. The company's mission is to advance psychedelic medicine and improve patient outcomes through its research and development initiatives.